Corporate Engagement

Our Corporate Engagement program promotes corporate responsibility regarding all aspects of reproductive and maternal health.

Rhia Ventures works with investors in publicly traded stocks who are committed to leveraging their investment portfolios to effect positive social outcomes. Together, we engage directly with companies in dialogue; attend shareholder meetings; file shareholder proposals; and provide thought leadership through our research, reports, and other publications.

In 2020, Rhia Ventures released Hidden Value: The Business Case for Reproductive Health, a groundbreaking report that connects how access to comprehensive reproductive health care impacts a company’s bottom line and the corporate workforce. Prepared in partnership with the consultancy FSG, the report identifies five major factors that argue for making access to reproductive health care a business imperative.

How Companies Can Strengthen Reproductive Health Care (Brief) is written for corporate leaders seeking to understand how to take action and strengthen their reproductive health care.

SB8, the new law that took effect in Texas on Tuesday, September 1, after the U.S. Supreme Court denied an emergency appeal from abortion providers, directly violates the precedent established in the landmark 1973 case of Roe v. Wade. Click on the image below to access our recommendations to private employers on how to mitigate the impacts to workers from Texas abortion ban, and help forestall copycat bills in other states.

From Here to Maternity: The Business Case for Strong Maternal Healthcare Coverage in the Private Sector (2021) is written for corporate leaders seeking to understand how strong maternal healthcare benefits can improve employee health and well-being; help create a healthier, more stable, and more diverse talent pool; contribute to greater retention, and reduce both absenteeism and presenteeism. It is also for the investment community, particularly the growing number of investors integrating corporate ESG (environmental, social, and governance) performance into their investment decision-making, as well as other private-sector employees, consultants, lawmakers, and the media.

Our

Goals

Educate

investor and corporate audiences on the economy-wide and firm-level benefits of improving access to affordable reproductive and maternal health care.

Give visibility and voice

to investors who support choice, contraception and maternal and reproductive health.

Advocate

for companies to provide first-rate reproductive health insurance coverage that covers all forms of contraception as well as elective abortion; generous parental and family leave policies; fertility benefits; support for child care; and protection against pregnancy discrimination.

Inspire

companies to support public policies that uphold these rights, values, and priorities.

Encourage

companies to ensure that their political spending and lobbying activities do not undermine these values and priorities.

For more information, contact
Shelley Alpern, Director of Shareholder Advocacy, at shareholderadvocacy@rhiaventures.org